Latest filing published 14 Apr 2026 for Bioventus Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mark Leonard Singleton is a declared insider of Bioventus Inc., with filings sourced from SEC (Form 4). In total, 26 filings cover trades dated from 21 March 2023 to 10 April 2026.
Every open-market trade on record is a sale: 9 sales worth €422k. Outside the open market, there are 4 share grants and 13 option exercises.
The latest filing, published on 14 April 2026, reports a share grant of €44k in Bioventus Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations